Drug & intervention
trabectedin
RxCUI 1716278
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
5 shownATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)NCT02194231 · 2013-07-01
COMPLETEDA Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the ElectrocardiogramNCT00786838 · 2008-10-01
COMPLETEDAn Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast CancerNCT00580112 · 2007-06-01
COMPLETEDA Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate CancerNCT00072670 · 2004-01-01
COMPLETEDEcteinascidin 743 in Treating Patients With Malignant MesotheliomaNCT00027508 · 2001-07-01
TERMINATEDConditions being studied
Research locations
BostonMassachusetts, United States2MarseilleFrance2New YorkNew York, United States2VillejuifFrance2BrusselsBelgium1CharlotteNorth Carolina, United States1ColumbiaMissouri, United States1DallasTexas, United States1DenverColorado, United States1EdegemBelgium1HoustonTexas, United States1IndianapolisIndiana, United States1
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.